Hepatocellular steatosis, low circulating LDL-C, and hypobetalipoproteinemia are particularly common among HCV genotype 3 (GT3) patients, due to viral-mediated inhibition of the microsomal triglyceride transfer protein [5,6,7]. This evidence concerns the gene MTTP and hypobetalipoproteinemia.